Many provinces and cities have issued documents, and the transfer of local medical insurance supplements has entered a critical period

Not long ago, the Sichuan Provincial Medical Insurance Bureau and other two departments issued the "Notice on Further Improving the Digestion of Class B Drugs in Basic Medical Insurance, Work Injury Insurance and Maternity Insurance in Our Province.
" Medicines will no longer be included in the payment scope of Sichuan Province's medical insurance from January 1, 2022
.
Before the above-mentioned drugs are transferred out, continue to be paid according to regulations
.
The "Notice" requires strict implementation of the time limit for drug recall, and no local modification or reservation shall be allowed in any form
.
All localities must do a good job in maintaining the information of the drug catalog database, and urge the designated medical institutions in the medical insurance area to update the information in a timely manner to ensure timely implementation and orderly transition
.
According to the "Notice of the Ministry of Human Resources and Social Security of the National Medical Insurance Administration on Printing and Distributing the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog" on August 10, 2019, all provinces must gradually digest the original provincial drug catalog within 3 years Class B drugs increased in accordance with regulations
.
In addition, according to the "Notice on Doing a Good Job in Basic Medical Security for Urban and Rural Residents in 2021" issued by the National Medical Insurance Bureau and other three departments, all provinces (autonomous regions and municipalities) must complete the digestion of the second batch of 40% supplementary varieties before the end of June 2021.
Work
.
In other words, from July of this year to the middle of next year, it is a critical period for local medical insurance supplements to be transferred out
.
At present, in addition to Sichuan Province, many provinces and cities, such as Anhui, Guizhou, Zhejiang, Jiangsu, etc.
, have issued relevant documents to arrange for specific varieties to be called out
.
Among them, according to the notice issued by the Xinjiang Medical Insurance Bureau, it is clear that starting from January 1, 2022, the "Xinjiang Uygur Autonomous Region and Xinjiang Production and Construction Corps Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog" will be added to the non-ethnic medicines All 305 varieties were transferred out of the scope of medical insurance payment
.
The notice issued by the Anhui Medical Insurance Bureau on the digestion of the original provincial-level supplementary class B drugs shows that there are 411 original provincial-level supplementary class B drugs in Anhui Province, most of which have been digested in batches, and 149 drugs will be released in December 2021.
31 days ago, the medical insurance catalogue of Anhui Province and the scope of the outpatient chronic disease drug catalogue were released
.
The Guizhou Medical Insurance Bureau issued a notice stating that from January 1, 2022, 339 drugs such as cidiiodine will be transferred out of the "Drug List
.
" Before the above-mentioned drugs are transferred out, continue to pay in accordance with the relevant provisions of the "Drug List"
.
The Zhejiang Provincial Medical Insurance Bureau has made it clear that from January 1, 2022, 118 drugs including amoxicillin and dicloxacillin will be transferred out of the Zhejiang Provincial Medical Insurance Catalog
.
The Jiangsu Provincial Medical Insurance Bureau also issued a document stating that starting from January 1, 2022, the cost of all imported drugs will no longer be included in the scope of payment in the Jiangsu Basic Medical Insurance Catalog
.
In addition, according to the arrangement of the Chongqing Medical Insurance Bureau, the digestion time schedule for the transfer of Chongqing local medical insurance products is: digestion drugs in the first year, and medical insurance reimbursement will cease from January 1, 2021; digestion drugs in the second year, from January 2022 Medical insurance reimbursement will cease on the 1st; for digestion medicines in the third year, medical insurance reimbursement will cease on July 1, 2022
.
Judging from the timing of transfers from various places, a large number of drugs will be intensively transferred to local medical insurance before January 1, 2022, including some sales of cerebroside carnosine injections, cefoperazone tazobactam injections, and oxiracetam injections.
A large variety of over one billion
.
The industry believes that as these varieties are transferred out of local medical insurance, they will face a greater impact and become self-funded medicines to move to the third terminal and medical e-commerce or new outlets
.